Soleno Therapeutics Inc (SLNO) stock news · rev $190.4M
Soleno Therapeutics Inc (SLNO) is a biotechnology company listed on NASDAQ.
This SLNO news page leads with what Soleno Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for SLNO yet. We will not pad this page with generic market recap.
Latest reported SLNO revenue for 2025-12-31 was $190.4M. Net income was $20.9M. SLNO currently screens at market cap $2.76B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the SLNO stock page; for the tape open the quote page.
SLNO stock news FAQ
What are SLNO's latest revenue and net income?
Latest cached Soleno Therapeutics Inc (SLNO) revenue for Dec 31, 2025 was $190.4M. Net income was $20.9M. Statements: https://lician.com/financials/slno
What is SLNO's market cap?
Soleno Therapeutics Inc (SLNO) market cap is $2.76B on the latest cached fundamentals snapshot.
What kind of company is SLNO?
Soleno Therapeutics Inc (SLNO) is a biotechnology company listed on NASDAQ.
Where is SLNO stock news listed?
Cached stock news for Soleno Therapeutics Inc (SLNO) is listed at https://lician.com/news/slno. Filings: https://lician.com/sec/slno
Not investment advice.